The following drugs or services are not subject to coverage under § 58-17-101:
(1) Any drug that is used in research trials sponsored by the manufacturer of that drug or a governmental entity; or
(2) Any drug or service furnished in a research trial, if the sponsor of the research trial furnishes the drug or service without charge to any participant in the research trial.